BRANDY HENRIKSON: Open Payments
NPI 1114551272 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 16 payments from 11 companies in 2025. Trend: 2023 $248 · 2024 $533 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $102 |
| United Therapeutics Corporation | 3 | $93 |
| Grifols USA, LLC | 2 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| La Jolla Pharmaceutical Company | 1 | $17 |
Products named: AUSTEDO XR, Tyvaso, Prolastin-C Liquid, INGREZZA, OFEV, OPSUMIT, TRELEGY ELLIPTA, DUPIXENT.
Industry payments across MI — which companies pay providers there.
